Search

everythinglearnresearchcommunity

for

Search:↓

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Contact immunotherapy can improve hair regrowth in alopecia areata patients.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Special cells can help regrow hair in alopecia areata.

DPCP treatment for alopecia areata can sometimes cause vitiligo.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Alopecia areata is hard to treat, but new targeted therapies show promise.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Photodynamic therapy with methyl 5-aminolevulinic acid is ineffective for treating alopecia totalis.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.